Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-Free Anesthesia in TMJ Surgery
NCT04724759Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine, ketamine, Lidocaine Hydrochloride Injection, without epinephrine in temporomandibular joint disorders (TMD), sponsored by Massachusetts General Hospital. Started Jun 2021; status: completed.
02
Drugs
dexmedetomidineketamineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
temporomandibular joint disorders (TMD)
Beyond the preview
Go deeper on NCT04724759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04724759.